NMPA Approval

Sodium Zirconium Cyclosilicate Powder

Approval Number

国药准字HJ20190072

Registration Date

May 31, 2024

Previous Approval Numbers

H20190072

Drug Information

Generic Name

环硅酸锆钠散

Trade Name

利倍卓

Dosage Form

散剂

Strength

Drug Type

化学药品

Registration Date

May 31, 2024

Expiry Date

May 30, 2029

Company Address

SE-151 85 Sodertalje, Sweden

Company Address

4545 Assembly Drive, Rockford, Illinois, 61109, USA

Empowering clinical research with data-driven insights and AI-powered tools.

环硅酸锆钠散 - NMPA 批准文号 | MedPath